Literature DB >> 17999041

[Anaphylaxis in childhood and adolescence].

H Ott1, S Lehmann, G Wurpts, H-F Merk, A Viardot-Helmer, E Rietschel, J M Baron.   

Abstract

Anaphylaxis represents a severe, systemic and potentially fatal hypersensitivity reaction that severely impairs the life of affected children and their caregivers. With an estimated life time prevalence of 0.05% to 2%, it is not a rare disease. Therefore every physician caring for children at risk for anaphylaxis should be familiar with this disease pattern. Foods are the most frequent triggers in children; less frequent causes include drugs and insect venom. Particularly in case of idiopathic anaphylaxis, systemic mastocytosis should be ruled out as a potential differential diagnosis in this age group as well. First line emergency treatment consists of parenteral epinephrine in a weight-adjusted dosage, and after cardiovascular stabilization systemic antihistamines and corticosteroids as well as inhaled beta-mimetics can be administered. Affected patients, their relatives and other caregivers should receive extensive training in order to guarantee an adequate emergency management of anaphylactic children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999041     DOI: 10.1007/s00105-007-1435-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  27 in total

Review 1.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

Review 2.  Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review.

Authors:  Holly C Shaffer; Daniel J Parsons; David B Peden; Dean Morrell
Journal:  J Am Acad Dermatol       Date:  2006-05       Impact factor: 11.527

3.  Treating anxiety in children with life-threatening anaphylactic conditions.

Authors:  Suneeta Monga; Katharina Manassis
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-08       Impact factor: 8.829

4.  Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis?

Authors:  F E Simons; X Gu; L M Johnston; K J Simons
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

Review 5.  Self-injectable epinephrine for first-aid management of anaphylaxis.

Authors:  Scott H Sicherer; F Estelle R Simons
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

6.  Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.

Authors:  Kari Bohlke; Robert L Davis; Frank DeStefano; S Michael Marcy; M Miles Braun; Robert S Thompson
Journal:  J Allergy Clin Immunol       Date:  2004-03       Impact factor: 10.793

7.  The psychosocial impact of anaphylaxis on young people and their parents.

Authors:  N Akeson; A Worth; A Sheikh
Journal:  Clin Exp Allergy       Date:  2007-08       Impact factor: 5.018

8.  Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis.

Authors:  F Estelle R Simons
Journal:  Novartis Found Symp       Date:  2004

9.  A 6-month old with total body flushing and a macular-papular lesion.

Authors:  Heather Conrad; Marianne Gausche-Hill; David Burbulys
Journal:  Pediatr Emerg Care       Date:  2007-05       Impact factor: 1.454

10.  Flushing and increase of serum tryptase after mechanical irritation of a solitary mastocytoma.

Authors:  Caroline Bussmann; Tobias Hagemann; Julia Hanfland; Gerhard Haidl; Thomas Bieber; Natalija Novak
Journal:  Eur J Dermatol       Date:  2007-06-01       Impact factor: 3.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.